Logical Therapeutics Raises $16.9 Million
Logical Therapeutics Inc., a Waltham, Mass.-based drug developer focused on inflammatory disease, has raised $16.9 million in Series C funding. SV Life Sciences led the round, and was joined by fellow return backers Burrill & Company, Novo A/S and Novitas Capital. The company previously raised over $30 million, and its lead compund is designed to reduce the gastrointestinal side effects of non-steroidal anti-inflammatory drugs.
27 May 2010•2 mins read
